PNEUMONIA, VIRAL
Clinical trials for PNEUMONIA, VIRAL explained in plain language.
Never miss a new study
Get alerted when new PNEUMONIA, VIRAL trials appear
Sign up with your email to follow new studies for PNEUMONIA, VIRAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug AV-001 aims to help hospitalized pneumonia patients breathe easier
Disease control Recruiting nowThis study tests a new drug called AV-001 in 120 hospitalized adults with pneumonia who need extra oxygen. The drug is given daily for up to 28 days alongside standard care. The goal is to see if it is safe and helps patients recover faster from pneumonia caused by COVID-19 or ot…
Matched conditions: PNEUMONIA, VIRAL
Phase: PHASE2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could a cold sore virus treatment save ICU pneumonia patients?
Disease control Recruiting nowThis study tests whether the antiviral drug acyclovir helps people on breathing machines who have pneumonia and also have herpes simplex virus (HSV) in their lungs. About 616 adults in intensive care will be randomly assigned to receive acyclovir or no antiviral treatment. The go…
Matched conditions: PNEUMONIA, VIRAL
Phase: PHASE3 • Sponsor: Jena University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC